Avantium installs 150th Crystal16®
During the installation session researchers at Sanofi Aventis and Avantium staff made some time in the training program to celebrate the occasion with a glass of Champagne.
The Crystal16® was developed by Avantium to fulfill an unmet need in crystallization research: fast and reliable solubility information on small amounts of sample. With the Crystal16® being used in many laboratories, including the Top 20 Pharma companies, many different applications have been developed. Click here to read more.
The Crystal16® is being used in more than 15 different countries, spanning three continents. This "little pioneer" has become an industry standard.
About Avantium
Avantium is a leading technology company in the area of advanced high-throughput R&D operating in the energy, chemicals and pharmaceutical industries. The company develops products and processes in the area of biofuels, bio-based chemicals and novel crystal forms of existing drugs by applying its proprietary, high-throughput R&D technology.
Avantium has demonstrated the potential of this technology by providing R&D services and systems to more than 70 companies worldwide. Avantium's customer base includes many of the world's largest energy, chemicals and pharmaceutical companies, such as BP, Shell, Sasol, Pfizer and GSK. Avantium has more than 100 employees; its offices and head quarters are based in Amsterdam, The Netherlands.
For more information
Please contact Mariëtte Hoogendoorn at +31 20 586 8010 or visit our website www.avantium.com/pharma